About Advanced Therapies
Advanced Therapies is a Healthcare company based in Philadelphia (United States) founded in 1998, and was acquired by Altaris in December 2024. It operates as a biopharmaceutical products are manufactured on a contract basis. Its chief executive is Edward Hu. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity is ADVANCED THERAPIES, INC. Its competitors include KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Advanced Therapies was established in 1998 as a contract manufacturer in the biopharmaceutical sector. Operations are based in Philadelphia, United States, where services focused on producing biopharmaceutical products are provided to clients. Expertise in manufacturing processes for advanced therapies is utilized to support various biopharma needs, including formulation and production under regulatory standards. The company is led by CEO Edward Hu.
- Headquarters Philadelphia, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website advancedtherapies.com
- Social LinkedIn YouTube
- Acquired by Altaris (Dec 2024)
- Legal Name Advanced Therapies, Inc.
Investors in Advanced Therapies
Advanced Therapies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Altaris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm invests in the US | – | altariscap.com | New York, United States |
Investor details for Advanced Therapies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Advanced Therapies
37 people are tracked at Advanced Therapies (13 in leadership, 24 in team).
| Name | Role | Group |
|---|---|---|
Edward Hu | CEO | Leadership |
Andreas C. Solomos | Director | Leadership |
Don Schmidt | Assiciate Director Molecular Biology | Leadership |
Stephanie Angel | Associate Scientist/ Study Director - Electron Microscopy/ Virology | Leadership |
Adrienne Hayes | Associate Director Of Procurement | Leadership |
Andreas Papadopoulos | Director, Commercial Cell Therapy Manufacturing | Leadership |
Andrea Janiszewski | Senior Talent Acquisition Partner | Leadership |
Michie Ong | Executive Director | Leadership |
Issam Ismaili | Director Of Clinical Manufacturing Ops Cell Gene Therapy | Leadership |
Karen (Mba | Director, Regulatory Affairs | Leadership |
Cesar Fernandes | Director Of IT Infrastructure | Leadership |
Liu Yalin | Associate Director | Leadership |
Ken Qian | HR Business Partner | Leadership |
Jason Wetherill | Lead System Administrator | Team |
Thamara Hewavitharana | Scientist | Team |
Lashawna Griffith B.s. M.p.h. | Environmental Health Safety Specialist | Team |
Cheryl Hinton | Associate Project Manager I | Team |
Mits James | Manufacturing Lead | Team |
Jiong Wang | Manager Of Analytic Development Virology Team | Team |
Whitney K. | Master Planner Testing Operations | Team |
17 more people are available in the full profile.
Complete people profiles for Advanced Therapies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Advanced Therapies
2 dated milestones of Advanced Therapies across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Advanced Therapies is founded.
- Exit Acquired by Altaris.
Competitors of Advanced Therapies
Advanced Therapies has 9 listed competitors in our database, 6 of them funded. They include KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $18.29M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| aldevron.com | 1998 | Fargo, United States | – | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | |
| kemwellbiopharma.com | 1980 | Bengaluru, India | $5.72M | 298 | Integrated biologics development and manufacturing are provided as a CDMO. | |
| eurogentec.com | 1985 | Seraing, Belgium | – | 426 | Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. | |
| ovagen.ie | 2000 | Mayo, Ireland | $25.21M | – | Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services | |
| laurus.bio | 2005 | Bengaluru, India | $18.89M | 6,094 | Precision fermentation services for biopharma and food are provided. | |
| idt-biologika.com | 1921 | Dessau Rosslau, Germany | – | – | Vaccines and biologics are developed and manufactured by IDT Biologika. | |
| eirgenix.com | 2012 | Taipei, Taiwan | $90.58M | – | Biologics development and manufacturing services are offered by EirGenix. | |
| omniabio.com | 2001 | Rockville, United States | $25.4M | – | Process development and manufacturing services for biologics are provided. |
Detailed competitors of Advanced Therapies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Advanced Therapies
The website of Advanced Therapies (advancedtherapies.com) receives about 4K visits a month and ranks #4,017,069 among all websites worldwide, #5,048 in Biotechnology and Pharmaceuticals.
- Monthly visits4K
▼ 5.9% vs previous month
- Unique visitors1.9K
per month
- Global rank#4,017,069
among all websites
- Category rank#5,048
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.9
- Average visit18 sec
- DevicesDesktop 35% · Mobile 65%
Websites whose visitors overlap most with Advanced Therapies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wuxiapptec.com | 100% | 107.6K | #296,852 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Advanced Therapies (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Advanced Therapies
Complete news archive for Advanced Therapies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advanced Therapies
Advanced Therapies was founded in 1998.
Advanced Therapies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Edward Hu is the current CEO of Advanced Therapies.
Advanced Therapies was established in 1998 as a contract manufacturer in the biopharmaceutical sector. Operations are based in Philadelphia, United States, where services focused on producing biopharmaceutical products are provided to clients. Expertise in manufacturing processes for advanced therapies is utilized to support various biopharma needs, including formulation and production under regulatory standards. The company is led by CEO Edward Hu.
Advanced Therapies's top competitors include KBI Biopharma, Aldevron and Ovagen.
Advanced Therapies has 1 investor. Key investors include Altaris.
Advanced Therapies operates through Advanced Therapies, Inc..
Yes. Advanced Therapies was acquired by Altaris in December 2024.